- Gainers: Hoth Therapeutics (NASDAQ:HOTH) +96%. Aytu BioScience (NASDAQ:AYTU) +38%. Accelerate Diagnostics (NASDAQ:AXDX) +34%. Biomerica (NASDAQ:BMRA) +23%. Innate Pharma (NASDAQ:IPHA) +22%.
- Losers: Bellerophon Therapeutics (NASDAQ:BLPH) -34%. Viela Bio (NASDAQ:VIE) -22%. Atreca (NASDAQ:BCEL) -17%. Stoke Therapeutics (NASDAQ:STOK) -17%. IMV (NASDAQ:IMV) -15%.